The end of randomised control trials is on the cards, a healthcare data expert predicts. The end of randomised control trials is on the cards, a healthcare data expert predicts. Speaking at the Wired ...

Kamala Nehru, Jawaharlal Nehru’s wife, fell victim to the old enemy, tuberculosis (TB), in a far-off Swiss sanatorium in 1936. Her privileged social standing could not save Kamala. A stark reminder of ...

This practical guide speaks to two audiences: those who read and those who conduct research. Clinicians are medical detectives by training. For each patient, they assemble clinical clues to establish ...

The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...

Relationship of body mass index and plasma imatinib levels in CML patients and mitigation of clinical impact using PK-guided dosing strategy. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...

The leadership team also includes Salvatore Leo (CEO and Founder, Royal Biologics), Jim Blasingame (Business Development, Royal Wound-X), and Mary Jo Murino (Operations, Royal Wound-X), ensuring ...

We preselected all newsletters you had before unsubscribing.

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...

A recent article in Community Care highlighted concerns from the social work academic community about a research proposal from the children’s social care What Works Centre. On offer from the ...

Can the mass media cause changes in an audience’s knowledge, attitudes and intention to practise behaviours? At BBC Media Action, we have just successfully conducted a randomised control trial (RCT) ...